Excerpts

Despite the barely missed significance in our study ( p = 0.052), there was a notable trend towards a higher sepsis rate.

Bedouin ethnical group was a protective factor for one-year mortality (hazard ratio (HR), 0.68; 95% CI 0.48–0.97), p = 0.034, and a trend for being protective with borderline significance in 30-day mortality (HR, 0.65; 95% CI 0.42–1.004, p = 0.052).

LAWT in the middle, right parts and the mean of all three parts (left, middle, and right) were associated with CE stroke on univariable analysis (OR 1.8; CI: 1.24–2.62, p = 0.002, OR 1.55; CI: 1.08–2.21, p = 0.017 and OR 1.68; CI: 1.05–2.71, p = 0.032, respectively), as well as after adjusting for CHA 2 DS 2 -VASc score and LA diameter in the multivariable regression model (OR 1.94; CI: 1.26–3.0, p = 0.003 and OR 1.57; CI: 1.07–2.31, p = 0.021, respectively), whereas the mean LAWT only showed a borderline significant association (OR 1.66; CI: 1.0–2.75, p = 0.052). 14 out of 56 (25%) CE patients had LAA filling defects in CTA.

It should be pointed out here that this is in disagreement with the fact that ECV showed a trend to be increased in patients with Perugini grade 3 compared to Perugini grade 2 ( p = 0.052).

Switch Cost Effect Regarding global switch costs, paired t -test found a near-significant difference ( t (19) = −2.08, p = 0.052) between the two exercise sessions.

The difference in recipient age was borderline significant (60.9 years vs. 59.0 years, p = 0.052).

However, there was a borderline significant difference in the delayed recall sub-score (2.3 ± 1.6 for cases vs. 3.4 ± 1.5 for controls, p = 0.052) and a significant difference in its sub-domain, the memory index score (MIS, 9.1 ± 4.3 for cases vs. 12.1 ± 3.0 for controls, p = 0.02).

Furthermore, medial and lateral dislocation had a strong trend to an overall increased complication rate ( p = 0.052).

Antiplatelet therapy showed a trend toward more frequent ticagrelor use in the SGLT2 inhibitor group (56% vs. 41%) and reciprocal clopidogrel use in untreated patients (59% vs. 44%; p = 0.052).

For PFS, the score test approached significance (χ 2 = 9.409, p = 0.052) and the change-from-block test was significant (χ 2 = 11.078, p = 0.026); lung metastasis was the only significant covariate (HR = 6.037, 95% CI: 1.390–26.230; p = 0.016), while other sites were non-significant ( Table 2 ).

A bivariate regression analysis revealed a marginally significant ( p = 0.052) association between median SWE after 2.5 years and the first COVID-19 severity (R 2 = 0.06).

Additionally, the P50 amplitude from the PERG showed borderline significance (r = 0.237, p = 0.052).

The difference between antrum-positive and corpus-positive groups approached significance ( p = 0.052), suggesting a potential association between antral colonization and altered esophageal contractility ( Table 4 ).

In the depression/anxiety group, antipsychotic prescriptions were significantly associated with SC (OR = 5.25, p = 0.033), while total prescriptions approached significance (OR = 4.35, p = 0.052), supporting the robustness of the main findings across diagnostic subgroups ( Table S7 ). 4.

No significant differences were found in FEV1 ( p = 0.227), while FVC showed a borderline significance ( p = 0.052).

The associations of RBP4 and retinol with the presence of MetS remained close to significance after adjustment for age and sex (retinol: β = 0.223, p = 0.052 and RBP4: β = 0.224, p = 0.051; data not shown).

When all other contributors were 0, the total hip BMD was 0.853 ± 0.402 g/cm 2 , with borderline significance ( p = 0.052).

The metastatic risk group demonstrated borderline significance ( p = 0.052).

Although graft localization showed a trend toward influencing outcomes, this did not reach statistical significance ( p = 0.052). 3.4.2.

In contrast, a recent study with oral administration of Limosilactobacillus reuteri ATCC PTA 6475 to IBS-D patients showed a trend toward reduced serum IL-6 levels compared to the placebo group ( p = 0.052) [ 44 ].

This change was clinically relevant but did not quite reach statistical significance ( p = 0.052) and the effect size was large (d = 0.892).

Those treated with non–anti-TNF biologics had a lower IR of 1679.0 and a borderline significant reduction in risk (HR = 0.8, 95% CI = 0.7–1.0, p = 0.052).

A moderate positive correlation of the Haller index with the MRC-DS dyspnoea scale was demonstrated (r = 0.40), with borderline significance ( p = 0.052).

Endocarditis remained associated with mortality at borderline significance (HR 4.32, 95% CI 0.99–18.86; p = 0.052; see Figure 2 ), and NYHA IV was similarly borderline (HR 4.86, 95% CI 0.98–24.14; p = 0.053; see Figure 3 ).

However, when entering the perioperative low cardiac output, a well-recognized predictor of hospital death, and AST in a multivariable analysis, both variables maintained a strong trend toward significance in predicting early mortality ( p = 0.052, OR [95% CIs] = 1.04 [1–1.08] for AST; and p = 0.048, OR [95% CIs] = 6.9 [1.06–45.0] for low cardiac output).